SHVMS LLC

04/14/2026 | Press release | Archived content

Biotech VCs, used to a winning formula in drug development, face disruption

The rise of Chinese biotech and promise of AI are suddenly scrambling the industry's playbook

Read the full article here.

SHVMS LLC published this content on April 14, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on June 18, 2026 at 10:54 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]